Process for making hydroxylated cyclopentylpyrimidine compounds

US9416110B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9416110-B2
Application numberUS-201314401087-A
CountryUS
Kind codeB2
Filing dateMay 17, 2013
Priority dateMay 17, 2012
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides processes for preparing a compound of formula I and salts thereof, wherein R 1 is defined herein, and compounds and intermediates of said formula.

First claim

Opening claim text (preview).

We claim: 1. A compound of formula IV: or a salt thereof, wherein: R 2 is —CN, —COOR a or —CONR a R b ; R a and R b are independently hydrogen, —OR c , substituted or unsubstituted C 1-12 alkyl, substituted or unsubstituted C 2-12 alkenyl, substituted or unsubstituted C 2-12 alkynyl, substituted or unsubstituted C 3-8 cycloalkyl, substituted or unsubstituted phenyl or substituted or unsubstituted 3 to 12 membered heterocyclyl; or R a and R b are taken together with the atom to which they are attached to form a 3-7 membered heterocyclyl; R c is independently hydrogen or optionally substituted C 1-12 alkyl; and each R 3 is independently iodo or bromo. 2. The compound of claim 1 , wherein R 2 is —C(O)N(R a )OR c . 3. The compound of claim 1 , wherein each R 3 is iodo. 4. The compound of claim 1 , which is the compound:

Assignees

Inventors

Classifications

  • Antineoplastic agents · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • C07D239/70Primary

    condensed with carbocyclic rings or ring systems · CPC title

  • Halogen atoms or nitro radicals · CPC title

  • C07D239/42Primary

    One nitrogen atom (nitro radicals C07D239/30) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9416110B2 cover?
The invention provides processes for preparing a compound of formula I and salts thereof, wherein R 1 is defined herein, and compounds and intermediates of said formula.
Who is the assignee on this patent?
Array Biopharma Inc, Genentech Inc
What technology area does this patent fall under?
Primary CPC classification C07D239/70. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).